24/7 MarketNews

Breaking 24/7 Market News

2018-04-26T15:40:27+00:00 Apr. 11, 2018 10:21AM EST|

247MarketNews.com News Briefs and Commentary

The market is trying to climb out of this morning’s deep red open and among today’s headlines are the following.

Kraig Biocraft Laboratories’ new R&D Facility extends its competitive advantages and prepares for large scale production

New larger Hybrid Cocoons provide production excitement

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces follow up to its recently introduced new Hybrid Spider Silk Silkworm Cocoons, which were produced at the Company’s new research and development facility.

Development for the new hybrid was completed in-house, at Kraig Labs R&D facility using its Dragon Silk colony silkworms and a commercial mundane silkworm strain, which resulted in an estimated 100% increase in cocoon weight, compared to the cocoons that the Company was producing just four months ago in Indiana.

The Company understood that silkworms have been producing mundane silk for thousands of years and, that by employing the existing sericulture infrastructure, as well as expertise and traditions, it can cost effectively scale-up its transgenic spider silk silkworm production. According to Kraig Labs’ data, the Company should be able to commercialize some of the toughest natural fibers for almost the same cost as normal every day silk. (Link to full announcement: https://www.businesswire.com/news/home/20180411005327/en/Kraig-Biocraft-Laboratories%E2%80%99-New-Facility-Extends-Competitive)

Mark Zuckerberg’s second day on Capitol Hill

Facebook’s (NASDAQ: FB) CEO Mark Zuckerberg is set to testify a second day before the Senate Committee on the Judiciary and Committee on Commerce, Science, and Transportation. Yesterday’s two biggest revelations were that Zuckerberg plans to always offer a free version of the social media platform, yet seemingly opening the door for rolling out a paid version, and Facebook plans on using artificial intelligence tools in the next “5 to 10 years” to monitor and ban hate speech on the platform, but what constitutes hate speech remain hazy.

Caldwell Cassady & Curry Helps VirnetX Win $502.6 Million Verdict Against Apple

 

Dallas law firm wins another patent infringement trial for VirnetX

The Dallas-based intellectual property and business litigation law firm Caldwell Cassady & Curry has won a unanimous $502.6 million patent infringement verdict for Nevada-based VirnetX Inc. (NYSEAMERICAN: VHC) against Apple Inc. (NASDAQ: AAPL) in the U.S. District Court for the Eastern District of Texas, Tyler Division.

The 8-0 verdict handed down April 10 by a jury of five women and three men followed roughly three hours of deliberations. The seven-day trial focused on four VirnetX patents (U.S. Patent Nos. 6,502,135; 7,490,151; 7,418,504; and 7,921,211).

Jurors determined Apple's attempted redesign fell short following a 2016 trial that ended with a separate jury finding that the company infringed VirnetX's patents with the popular Facetime and VPN on Demand features used in the iPhone and other Apple products. (Link to full announcement: https://www.prnewswire.com/news-releases/caldwell-cassady--curry-helps-virnetx-win-502-6-million-verdict-against-apple-300628139.html)

Connect with 24/7 Market News on social mediahttps://twitter.com/247MarketNewsHQ

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:

24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

24/7MN has covered Kraig Biocraft Laboratories, Inc. in the past and owns shares. You may view this as a conflict of interest. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice.   24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

For further information on 24/7 Market News, please go to www.247marketnews.com

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MSC undertakes no obligation to update such statements

CONTACT:

24/7 Market News

Editor@247marketnews.com

Send this to a friend

Hi, this may be interesting you: Kraig Biocraft Laboratories’ New R&D Facility Extends Its Competitive Advantages and Prepares for Large Scale Production! This is the link: https://www.247marketnews.com/kraig-biocraft-laboratories-new-rd-facility-extends-its-competitive-advantages-and-prepares-for-large-scale-production/